Overview of Dr. Mapara
Dr. Markus Mapara is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. He received his medical degree from University of Heidelberg Faculty of Medicine and has been in practice 27 years. Dr. Mapara accepts several types of health insurance, listed below. He is one of 378 doctors at New York-Presbyterian Hospital and one of 116 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Oncology. He also speaks multiple languages, including German and French. He has more than 100 publications and over 500 citings.
Office
161 Ft Washingtn Ave
Herbert Irving Pavilion
New York, NY 10032Fax+1 412-235-1030
Education & Training
- University of Heidelberg Faculty of MedicineClass of 1990
Certifications & Licensure
- NY State Medical License 2011 - 2025
- PA State Medical License 2005 - 2014
- Internal MedicineHematology/Oncology
Clinical Trials
- Safety and Efficacy Study of an Anti-CD20 Monoclonal Antibody (AME-133v) to Treat Non-Hodgkin's Lymphoma Start of enrollment: 2006 Jul 01
- Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402) Start of enrollment: 2006 Nov 01
Publications & Presentations
PubMed
- 495 citationsCRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.Haydar Frangoul, David Altshuler, M Domenica Cappellini, Yi-Shan Chen, Jennifer Domm
The New England Journal of Medicine. 2021-01-21 - 52 citationsPhase 1a/b Study of Monoclonal Antibody CAEL-101 (11-1F4) in Patients with AL AmyloidosisCamille V Edwards, Nisha Rao, Divaya Bhutani, Markus Y. Mapara, Jai Radhakrishnan
Blood. 2021-09-14 - 164 citationsTime-intensified dexamethasone/cisplatin/cytarabine:an effective salvage therapy with low toxicity in patients with relapsed and refractory Hodgkin’s diseaseAndreas Josting, Christian Rudolph, Marcel Reiser, Markus Y. Mapara, M. Sieber
Annals of Oncology. 2002-10-01
Journal Articles
- Immunomodulatory Drugs Downregulate IKZF1 Leading to Expansion of Hematopoietic Progenitors with Concomitant Block of Megakaryocytic MaturationMarkus Y Mapara, Sara A Monaghan, Suzanne Lentzsch, Haematologica
- Brentuximab Vedotin and Bendamustine Produce High Complete Response Rates in Patients with Chemotherapy Refractory Hodgkin LymphomaChangchun Deng, Markus Y. Mapara, Ahmed Sawas, Matko Kalac, British Journal of Haematology
Abstracts/Posters
- Combination Chemotherapy with Carfilzomib, Bendamustine and Dexamethasone Is Highly Active for Therapy of Newly Diagnosed Multiple Myeloma-Results of Single Center Pha...Markus Y. Mapara, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Excellent Survival and Immune Reconstitution Following Matched/Mismatched Unrelated and Mismatched Related Transplantation in Adult Patients with Sickle Cell Disease: ...Markus Y Mapara, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Exploring the Drivers of Potential Clinical Benefit in Initial Patients Treated in the Hgb-206 Study of Lentiglobin for Sickle Cell Disease (SCD) Gene TherapyMarkus Y. Mapara, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Join now to see all
Press Mentions
- Actinium Announces FDA Clearance of Iomab-ACT Targeted Conditioning IND Application for Sickle Cell Disease Patients Undergoing Bone Marrow Transplant in Collaboration with Columbia UniversityJuly 25th, 2024
- A Gene Therapy Cure for Sickle Cell Is on the HorizonMarch 15th, 2023
- Boston University Reveals New Treatment for Sickle Cell AnemiaApril 9th, 2022
- Join now to see all
Grant Support
- Role Of STAT1 And STAT3 In Graft Versus Host Disease And Graft Versus Leukemia EFNational Heart, Lung, And Blood Institute2008–2011
Professional Memberships
- Member
- American Society of Blood and Marrow TransplantationMember
Other Languages
- German, French
External Links
- columbia Doctorshttp://columbiadoctors.org/find-a-provider?specialty=&lastname=mapara&insurance=-1&depId=-1&divId=0&language=-1&gender=-1&zipsearch=&pracid=&refine=Search
Insurance Accepted
- Empire BCBS PPO
Multiplan PHCS PPO
Multiplan PPO
Oxford Health FreedomOxford Health Liberty
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: